Qingyong Chen Selected Research

Qingyong Chen Research Topics

Disease

10	Lung Neoplasms (Lung Cancer) 11/2023 - 08/2003
8	Neoplasms (Cancer) 01/2022 - 03/2012
5	Adenocarcinoma of Lung 11/2023 - 06/2009
3	Heart Failure 03/2023 - 04/2017
3	Cardiac Arrhythmias (Arrythmia) 03/2023 - 01/2022
3	Neoplasm Metastasis (Metastasis) 01/2019 - 08/2003
3	Lymphatic Metastasis 01/2017 - 08/2003
3	Breast Neoplasms (Breast Cancer) 01/2015 - 01/2006
2	Tachycardia (Tachyarrhythmias) 03/2023 - 01/2022
2	Fibrosis (Cirrhosis) 01/2022 - 04/2017
2	COVID-19 01/2021 - 01/2020
2	Inflammation (Inflammations) 01/2018 - 04/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 04/2017
1	Atherosclerosis 04/2024
1	Postoperative Pain 03/2024
1	Atrial Fibrillation 01/2024
1	Pneumopericardium 03/2023
1	Ventricular Tachycardia 04/2022
1	Colitis 01/2022
1	Colitis-Associated Neoplasms 01/2022
1	End Stage Liver Disease 01/2022
1	Ascites 01/2022
1	Hemorrhage 01/2022
1	Liver Diseases (Liver Disease) 01/2022
1	Cardiomyopathies (Cardiomyopathy) 01/2022
1	Carcinogenesis 11/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2021
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021
1	Clinical Deterioration 01/2021
1	Infections 01/2021
1	Pneumonia (Pneumonitis) 01/2020
1	Acute Abdomen 01/2020
1	Hyperglycemia 01/2019
1	Abdominal Pain (Pain, Abdominal) 12/2018
1	Ileus 09/2018
1	Colonic Neoplasms (Colon Cancer) 09/2018
1	Brain Ischemia (Cerebral Ischemia) 01/2018
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 01/2017
1	Hamartoma 07/2015
1	Triple Negative Breast Neoplasms 01/2015

Drug/Important Bio-Agent (IBA)

4	Gefitinib (Iressa)FDA Link 11/2023 - 01/2018
4	Biomarkers (Surrogate Marker)IBA 01/2018 - 08/2016
4	MicroRNAs (MicroRNA)IBA 01/2017 - 01/2015
3	Long Noncoding RNAIBA 04/2024 - 01/2017
3	CurcuminIBA 01/2018 - 06/2009
3	Proteins (Proteins, Gene)FDA Link 10/2015 - 08/2003
2	Phosphotransferases (Kinase)IBA 04/2024 - 01/2018
2	VimentinIBA 01/2019 - 03/2012
2	omega-Chloroacetophenone (Mace)IBA 01/2018 - 04/2017
2	Messenger RNA (mRNA)IBA 01/2017 - 01/2006
1	mouse Itch proteinIBA 04/2024
1	Capsules (Microcapsules)IBA 03/2024
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2023
1	madecassic acidIBA 01/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2022
1	SodiumIBA 01/2022
1	TriterpenesIBA 01/2022
1	RNA IIBA 11/2021
1	Gemcitabine FDA Link 11/2021
1	Nucleic AcidsIBA 01/2021
1	mogroside VIBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Cadherins (E-Cadherin)IBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2018
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2018
1	Proto-Oncogene Proteins c-metIBA 01/2018
1	HMGB1 Protein (HMG1)IBA 01/2018
1	Janus KinasesIBA 01/2018
1	Galectin 3 (LGALS3)IBA 04/2017
1	Transcription Factors (Transcription Factor)IBA 01/2017
1	Sepharose (Agarose)IBA 10/2015
1	AlginatesIBA 10/2015
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 07/2015
1	Estrogen ReceptorsIBA 01/2015
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2015
1	Lim KinasesIBA 01/2013
1	Mucin-1 (CA 15-3 Antigen)IBA 03/2012
1	Cathepsin BIBA 07/2011
1	Plasminogen Activators (Plasminogen Activator)IBA 07/2011
1	Urokinase Plasminogen Activator ReceptorsIBA 07/2011
1	Cystatin CIBA 07/2011
1	Cathepsin LIBA 07/2011
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 07/2011
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2010

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 11/2021 - 01/2013
2	Catheter Ablation 01/2024 - 03/2023
1	Tissue Scaffolds 03/2024
1	Tonsillectomy 03/2024
1	Patient Readmission 03/2023
1	Radiotherapy 04/2022
1	Oral Administration 01/2022
1	Extracorporeal Membrane Oxygenation 01/2022
1	Transjugular Intrahepatic Portasystemic Shunt 01/2022
1	Enema (Enemas) 01/2021
1	Resuscitation 01/2021
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021
1	Length of Stay 01/2020
1	Lymph Node Excision (Lymph Node Dissection) 09/2018
1	Colectomy 09/2018